Topic

Pennsylvania

A collection of 524 issues

How to Get HyperHEP (Hepatitis B Immune Globulin) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting HyperHEP Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare typically requires prior authorization for HyperHEP (hepatitis B immune globulin) with strict timing windows for post-exposure prophylaxis. First step: Check your formulary tier and PA requirements through the UnitedHealthcare provider portal or call 1-800-711-4555. For denials, Pennsylvania offers a robust

How to Get Galafold (Migalastat) Covered by Cigna in Pennsylvania: Complete Guide with ICD-10, NDC Codes, and Appeal Process

Answer Box: Getting Galafold Covered by Cigna in Pennsylvania Eligibility: Adults ≥18 with confirmed Fabry disease and an amenable GLA variant documented by genetic testing. Fastest path: Submit prior authorization through Accredo (Cigna's specialty pharmacy) with ICD-10 code E75.21, genetic test results, and specialist letter. First step

Renewing Filsuvez (Birch Triterpenes Topical Gel) Approval with Cigna in Pennsylvania: Complete Timeline and Documentation Guide

Answer Box: Filsuvez Renewal with Cigna in Pennsylvania Cigna typically requires Filsuvez (birch triterpenes topical gel) prior authorization renewal every 6-12 months for epidermolysis bullosa patients. Start your renewal process 6-8 weeks before your current authorization expires to avoid treatment gaps. You'll need updated wound assessments, response documentation,

How to Get Takhzyro (lanadelumab-flyo) Covered by Humana in Pennsylvania: Appeals Guide, Forms & Success Strategies

Answer Box: Getting Takhzyro Covered by Humana in Pennsylvania Yes, Humana Medicare Advantage requires prior authorization for Takhzyro (lanadelumab-flyo) in Pennsylvania. The fastest path to approval: 1) Confirm your HAE diagnosis with documented C1-INH lab abnormalities and attack frequency ≥1 per month, 2) Have your allergist/immunologist submit a complete

Work With Your Doctor to Get Xospata (Gilteritinib) Covered by Blue Cross Blue Shield in Pennsylvania: Forms, Appeals, and Success Scripts

Answer Box: Getting Xospata Covered by Blue Cross Blue Shield in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania require prior authorization for Xospata (gilteritinib), which is approved for adults with relapsed/refractory FLT3-mutated AML. Success requires: (1) documented FLT3 mutation test results, (2) evidence of prior therapy failure, and

Myths vs. Facts: Getting Cabometyx (Cabozantinib) Covered by Cigna in Pennsylvania

Answer Box: To get Cabometyx covered by Cigna in Pennsylvania, you need prior authorization based on specific FDA-approved cancer indications (RCC, HCC, or DTC). Submit documentation showing diagnosis, prior therapy failures, and imaging evidence through your oncologist. If denied, Pennsylvania's new external review program has overturned ~50% of

How to Get Zolgensma (onasemnogene abeparvovec) Covered by Aetna (CVS Health) in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Zolgensma Covered by Aetna in Pennsylvania Aetna covers Zolgensma (onasemnogene abeparvovec) for spinal muscular atrophy under strict prior authorization requiring: confirmed bi-allelic SMN1 mutations, age under 24 months, anti-AAV9 antibody titer ≤1:50, and treatment at an approved gene therapy center. If denied, you have 180 days

How to Renew Crysvita (Burosumab) Coverage with Blue Cross Blue Shield in Pennsylvania: Complete Timeline and Documentation Guide

Answer Box: Renewing Your Crysvita Coverage in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania typically require annual reauthorization for Crysvita (burosumab) with documented clinical benefit and safety monitoring. Start your renewal 60-90 days before expiration to avoid gaps. Required documentation includes recent fasting serum phosphorus levels, alkaline phosphatase results,

How to Get Strensiq (asfotase alfa) Covered by UnitedHealthcare in Pennsylvania: Complete PA Forms, Appeals Timeline & Success Scripts

Answer Box: Getting Strensiq Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Strensiq (asfotase alfa) with strict pediatric-onset hypophosphatasia criteria. Fastest path: Submit PA through OptumRx with documented onset before age 18, genetic/biochemical confirmation, and specialist attestation. If denied, use Pennsylvania's external review program within

Myths vs. Facts: Getting Ilaris (Canakinumab) Covered by Cigna in Pennsylvania

Quick Answer: Cigna requires prior authorization for Ilaris (canakinumab) in Pennsylvania with specific criteria including specialist prescription, elevated CRP levels, and documented failure of standard therapies. If denied, you have 180 days for internal appeals, then 4 months for Pennsylvania's external review program, which overturns 50% of denials.